| Year |
Citation |
Score |
| 2024 |
Plastini MJ, Abdelnour C, Young CB, Wilson EN, Shahid-Besanti M, Lamoureux J, Andreasson KI, Kerchner GA, Montine TJ, Henderson VW, Poston KL. Multiple biomarkers improve diagnostic accuracy across Lewy body and Alzheimer's disease spectra. Annals of Clinical and Translational Neurology. PMID 38436140 DOI: 10.1002/acn3.52034 |
0.314 |
|
| 2024 |
Winer JR, Lok R, Weed L, He Z, Poston KL, Mormino EC, Zeitzer JM. Impaired 24-h activity patterns are associated with an increased risk of Alzheimer's disease, Parkinson's disease, and cognitive decline. Alzheimer's Research & Therapy. 16: 35. PMID 38355598 DOI: 10.1186/s13195-024-01411-0 |
0.434 |
|
| 2024 |
Cousins KAQ, Irwin DJ, Tropea TF, Rhodes E, Phillips J, Chen-Plotkin AS, Brumm MC, Coffey CS, Kang JH, Simuni T, Foroud TM, Toga AW, Tanner CM, Kieburtz KD, Mollenhauer B, ... ... Poston KL, et al. Evaluation of ATN Framework and Biofluid Markers to Predict Cognitive Decline in Early Parkinson Disease. Neurology. 102: e208033. PMID 38306599 DOI: 10.1212/WNL.0000000000208033 |
0.383 |
|
| 2023 |
Nerrise F, Zhao Q, Poston KL, Pohl KM, Adeli E. An Explainable Geometric-Weighted Graph Attention Network for Identifying Functional Networks Associated with Gait Impairment. Medical Image Computing and Computer-Assisted Intervention : Miccai ... International Conference On Medical Image Computing and Computer-Assisted Intervention. 14221: 723-733. PMID 37982132 DOI: 10.1007/978-3-031-43895-0_68 |
0.368 |
|
| 2023 |
Kerestes R, Laansma MA, Owens-Walton C, Perry A, van Heese EM, Al-Bachari S, Anderson TJ, Assogna F, Aventurato ÍK, van Balkom TD, Berendse HW, van den Berg KRE, Betts R, Brioschi R, Carr J, ... ... Poston KL, et al. Cerebellar Volume and Disease Staging in Parkinson's Disease: An ENIGMA-PD Study. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 37964373 DOI: 10.1002/mds.29611 |
0.449 |
|
| 2023 |
Nerrise F, Zhao Q, Poston KL, Pohl KM, Adeli E. An Explainable Geometric-Weighted Graph Attention Network for Identifying Functional Networks Associated with Gait Impairment. Arxiv. PMID 37547656 |
0.368 |
|
| 2023 |
Brumm MC, Siderowf A, Simuni T, Burghardt E, Choi SH, Caspell-Garcia C, Chahine LM, Mollenhauer B, Foroud T, Galasko D, Merchant K, Arnedo V, Hutten SJ, O'Grady AN, Poston KL, et al. Parkinson's Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson's Disease Progression. Journal of Parkinson's Disease. PMID 37458046 DOI: 10.3233/JPD-223433 |
0.491 |
|
| 2023 |
Weintraub D, Picillo M, Cho HR, Caspell-Garcia C, Blauwendraat C, Brown EG, Chahine LM, Coffey CS, Dobkin RD, Foroud T, Galasko D, Kieburtz K, Marek K, Merchant K, Mollenhauer B, ... Poston KL, et al. Impact of the Dopamine System on Long-Term Cognitive Impairment in Parkinson Disease: An Exploratory Study. Movement Disorders Clinical Practice. 10: 943-955. PMID 37332638 DOI: 10.1002/mdc3.13751 |
0.396 |
|
| 2023 |
Morris R, Martini DN, Kelly VE, Smulders K, Ramsey K, Hiller A, Chung KA, Hu SC, Zabetian CP, Poston KL, Mata IF, Edwards KL, Lapidus J, Cholerton B, Montine TJ, et al. Gait and balance in apolipoprotein Ɛ4 allele carriers in older adults and Parkinson's disease. Clinical Parkinsonism & Related Disorders. 9: 100201. PMID 37252677 DOI: 10.1016/j.prdoa.2023.100201 |
0.393 |
|
| 2023 |
Ryman SG, Shaff N, Dodd A, Nitschke S, Wertz C, Julio K, Suarez Cedeno G, Deligtisch A, Erhardt E, Lin H, Vakhtin A, Poston KL, Tarawneh R, Pirio Richardson S, Mayer A. Reduced and Delayed Cerebrovascular Reactivity in Patients with Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 37157056 DOI: 10.1002/mds.29429 |
0.489 |
|
| 2023 |
Fama R, Müller-Oehring EM, Levine TF, Sullivan EV, Sassoon SA, Asok P, Brontë-Stewart HM, Poston KL, Pohl KM, Pfefferbaum A, Schulte T. Episodic memory deficit in HIV infection: common phenotype with Parkinson's disease, different neural substrates. Brain Structure & Function. PMID 37069296 DOI: 10.1007/s00429-023-02626-x |
0.31 |
|
| 2023 |
Siderowf A, Concha-Marambio L, Lafontant DE, Farris CM, Ma Y, Urenia PA, Nguyen H, Alcalay RN, Chahine LM, Foroud T, Galasko D, Kieburtz K, Merchant K, Mollenhauer B, Poston KL, et al. Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study. The Lancet. Neurology. 22: 407-417. PMID 37059509 DOI: 10.1016/S1474-4422(23)00109-6 |
0.325 |
|
| 2022 |
Endo M, Poston KL, Sullivan EV, Fei-Fei L, Pohl KM, Adeli E. GaitForeMer: Self-Supervised Pre-Training of Transformers via Human Motion Forecasting for Few-Shot Gait Impairment Severity Estimation. Medical Image Computing and Computer-Assisted Intervention : Miccai ... International Conference On Medical Image Computing and Computer-Assisted Intervention. 13438: 130-139. PMID 36342887 DOI: 10.1007/978-3-031-16452-1_13 |
0.318 |
|
| 2022 |
Bukhari SA, Nudelman KNH, Rumbaugh M, Richeson P, Fox EJ, Montine KS, Aldecoa I, Garrido A, Franz J, Stadelmann C, Vonsattel JPG, Poston KL, Foroud TM, Montine TJ. Parkinson's Progression Markers Initiative brain autopsy program. Parkinsonism & Related Disorders. 101: 62-65. PMID 35803091 DOI: 10.1016/j.parkreldis.2022.06.017 |
0.394 |
|
| 2022 |
Morris R, Martini DN, Ramsey K, Kelly VE, Smulders K, Hiller A, Chung KA, Hu SC, Zabetian CP, Poston KL, Mata IF, Edwards KL, Lapidus J, Cholerton B, Montine TJ, et al. Cognition as a mediator for gait and balance impairments in GBA-related Parkinson's disease. Npj Parkinson's Disease. 8: 78. PMID 35725575 DOI: 10.1038/s41531-022-00344-5 |
0.366 |
|
| 2022 |
Cai W, Young CB, Yuan R, Lee B, Ryman S, Kim J, Yang L, Henderson VW, Poston KL, Menon V. Dopaminergic medication normalizes aberrant cognitive control circuit signalling in Parkinson's disease. Brain : a Journal of Neurology. PMID 35357463 DOI: 10.1093/brain/awac007 |
0.33 |
|
| 2022 |
Müller-Oehring EM, Hong JY, Poston KL, Brontë-Stewart HM, Sullivan EV, McGlynn L, Schulte T. Neurofunctional characteristics of executive control in older people with HIV infection: a comparison with Parkinson's disease. Brain Imaging and Behavior. PMID 35294979 DOI: 10.1007/s11682-022-00645-6 |
0.324 |
|
| 2021 |
Kern F, Fehlmann T, Violich I, Alsop E, Hutchins E, Kahraman M, Grammes NL, Guimarães P, Backes C, Poston KL, Casey B, Balling R, Geffers L, Krüger R, Galasko D, et al. Deep sequencing of sncRNAs reveals hallmarks and regulatory modules of the transcriptome during Parkinson's disease progression. Nature Aging. 1: 309-322. PMID 37118411 DOI: 10.1038/s43587-021-00042-6 |
0.388 |
|
| 2021 |
Cholerton BA, Poston KL, Yang L, Rosenthal LS, Dawson TM, Pantelyat A, Edwards KL, Tian L, Quinn JF, Chung KA, Hiller AL, Hu SC, Montine TJ, Zabetian CP. Semantic fluency and processing speed are reduced in non-cognitively impaired participants with Parkinson's disease. Journal of Clinical and Experimental Neuropsychology. 1-12. PMID 34355669 DOI: 10.1080/13803395.2021.1927995 |
0.381 |
|
| 2021 |
Lu M, Zhao Q, Poston KL, Sullivan EV, Pfefferbaum A, Shahid M, Katz M, Kouhsari LM, Schulman K, Milstein A, Niebles JC, Henderson VW, Fei-Fei L, Pohl KM, Adeli E. Quantifying Parkinson's disease motor severity under uncertainty using MDS-UPDRS videos. Medical Image Analysis. 73: 102179. PMID 34340101 DOI: 10.1016/j.media.2021.102179 |
0.325 |
|
| 2021 |
Patel SS, Müller-Oehring EM, DeVaughn S, Fama R, Brontë-Stewart HM, Poston KL, Schulte T. The effects of mood and cognition on daily functioning and quality of life in older people living with HIV and people with Parkinson's disease. Neuropsychology. PMID 34323563 DOI: 10.1037/neu0000760 |
0.3 |
|
| 2021 |
Laansma MA, Bright JK, Al-Bachari S, Anderson TJ, Ard T, Assogna F, Baquero KA, Berendse HW, Blair J, Cendes F, Dalrymple-Alford JC, de Bie RMA, Debove I, Dirkx MF, Druzgal J, ... ... Poston KL, et al. International Multicenter Analysis of Brain Structure Across Clinical Stages of Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 34288137 DOI: 10.1002/mds.28706 |
0.329 |
|
| 2021 |
Kremer T, Taylor KI, Siebourg-Polster J, Gerken T, Staempfli A, Czech C, Dukart J, Galasko D, Foroud T, Chahine LM, Coffey CS, Simuni T, Weintraub D, Seibyl J, Poston KL, et al. Longitudinal Analysis of Multiple Neurotransmitter Metabolites in Cerebrospinal Fluid in Early Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 33942926 DOI: 10.1002/mds.28608 |
0.424 |
|
| 2021 |
Ryman SG, Yutsis M, Tian L, Henderson VW, Montine TJ, Salmon DP, Galasko D, Poston KL. Cognition at Each Stage of Lewy Body Disease with Co-occurring Alzheimer's Disease Pathology. Journal of Alzheimer's Disease : Jad. PMID 33646154 DOI: 10.3233/JAD-201187 |
0.347 |
|
| 2021 |
Zarifkar P, Kim J, La C, Zhang K, YorkWilliams S, Levine TF, Tian L, Borghammer P, Poston KL. Cognitive impairment in Parkinson's disease is associated with Default Mode Network subsystem connectivity and cerebrospinal fluid Aβ. Parkinsonism & Related Disorders. 83: 71-78. PMID 33484978 DOI: 10.1016/j.parkreldis.2021.01.002 |
0.416 |
|
| 2020 |
Das T, Kim N, McDaniel C, Poston KL. Mnemonic Similarity Task to study episodic memory in Parkinson's disease. Clinical Parkinsonism & Related Disorders. 3: 100062. PMID 34316643 DOI: 10.1016/j.prdoa.2020.100062 |
0.375 |
|
| 2020 |
Prabhakar V, Martin T, Müller-Oehring EM, Goodcase R, Schulte T, Poston KL, Brontë-Stewart HM. Quantitative Digitography Measures Fine Motor Disturbances in Chronically Treated HIV Similar to Parkinson's Disease. Frontiers in Aging Neuroscience. 12: 539598. PMID 33132893 DOI: 10.3389/fnagi.2020.539598 |
0.302 |
|
| 2020 |
Lu M, Poston K, Pfefferbaum A, Sullivan EV, Fei-Fei L, Pohl KM, Niebles JC, Adeli E. Vision-based Estimation of MDS-UPDRS Gait Scores for Assessing Parkinson's Disease Motor Severity. Medical Image Computing and Computer-Assisted Intervention : Miccai ... International Conference On Medical Image Computing and Computer-Assisted Intervention. 12263: 637-647. PMID 33103164 DOI: 10.1007/978-3-030-59716-0_61 |
0.434 |
|
| 2020 |
Martini DN, Morris R, Kelly VE, Hiller A, Chung KA, Hu SC, Zabetian CP, Oakley J, Poston K, Mata IF, Edwards KL, Lapidus JA, Grabowski TJ, Montine TJ, Quinn JF, et al. Sensorimotor Inhibition and Mobility in Genetic Subgroups of Parkinson's Disease. Frontiers in Neurology. 11: 893. PMID 33013627 DOI: 10.3389/Fneur.2020.00893 |
0.434 |
|
| 2020 |
Phongpreecha T, Cholerton B, Mata IF, Zabetian CP, Poston KL, Aghaeepour N, Tian L, Quinn JF, Chung KA, Hiller AL, Hu SC, Edwards KL, Montine TJ. Multivariate prediction of dementia in Parkinson's disease. Npj Parkinson's Disease. 6: 20. PMID 32885039 DOI: 10.1038/S41531-020-00121-2 |
0.357 |
|
| 2020 |
Linortner P, McDaniel C, Shahid M, Levine TF, Tian L, Cholerton B, Poston KL. White Matter Hyperintensities Related to Parkinson's Disease Executive Function. Movement Disorders Clinical Practice. 7: 629-638. PMID 32775508 DOI: 10.1002/mdc3.12956 |
0.434 |
|
| 2020 |
Gryc W, Roberts KA, Zabetian CP, Weintraub D, Trojanowski JQ, Quinn JF, Hiller AL, Chung KA, Poston KL, Yang L, Hu SC, Edwards KL, Montine TJ, Cholerton BA. Hallucinations and Development of Dementia in Parkinson's Disease. Journal of Parkinson's Disease. PMID 32741842 DOI: 10.3233/Jpd-202116 |
0.445 |
|
| 2020 |
Mormino EC, Toueg TN, Azevedo C, Castillo JB, Guo W, Nadiadwala A, Corso NK, Hall JN, Fan A, Trelle AN, Harrison MB, Hunt MP, Sha SJ, Deutsch G, James M, ... ... Poston K, et al. Tau PET imaging with F-PI-2620 in aging and neurodegenerative diseases. European Journal of Nuclear Medicine and Molecular Imaging. PMID 32572562 DOI: 10.1007/S00259-020-04923-7 |
0.347 |
|
| 2020 |
Poston KL, Ua Cruadhlaoich MAI, Santoso LF, Bernstein JD, Liu T, Wang Y, Rutt B, Kerchner GA, Zeineh MM. Substantia Nigra Volume Dissociates Bradykinesia and Rigidity from Tremor in Parkinson's Disease: A 7 Tesla Imaging Study. Journal of Parkinson's Disease. 10: 591-604. PMID 32250317 DOI: 10.3233/Jpd-191890 |
0.457 |
|
| 2020 |
Simuni T, Brumm MC, Uribe L, Caspell-Garcia C, Coffey CS, Siderowf A, Alcalay R, Trojanowski JQ, Shaw LM, Seibyl J, Singleton A, Toga AW, Galasko D, Foroud T, Nudelman K, ... ... Poston K, et al. Clinical and Dopamine Transporter Imaging Characteristics of Leucine- Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross-Sectional Study. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 32073681 DOI: 10.1002/Mds.27989 |
0.463 |
|
| 2020 |
Wilson EN, Swarovski MS, Linortner P, Shahid M, Zuckerman AJ, Wang Q, Channappa D, Minhas PS, Mhatre SD, Plowey ED, Quinn JF, Zabetian CP, Tian L, Longo FM, Cholerton B, ... ... Poston KL, et al. Soluble TREM2 is elevated in Parkinson's disease subgroups with increased CSF tau. Brain : a Journal of Neurology. PMID 32065223 DOI: 10.1093/Brain/Awaa021 |
0.425 |
|
| 2020 |
Cholerton B, Poston KL, Tian L, Quinn JF, Chung KA, Hiller AL, Hu SC, Specketer K, Montine TJ, Edwards KL, Zabetian CP. Participant and Study Partner Reported Impact of Cognition on Functional Activities in Parkinson's Disease. Movement Disorders Clinical Practice. 7: 61-69. PMID 31970213 DOI: 10.1002/Mdc3.12870 |
0.395 |
|
| 2019 |
Morris R, Martini DN, Smulders K, Kelly VE, Zabetian CP, Poston K, Hiller A, Chung KA, Yang L, Hu SC, Edwards KL, Cholerton B, Grabowski TJ, Montine TJ, Quinn JF, et al. Cognitive associations with comprehensive gait and static balance measures in Parkinson's disease. Parkinsonism & Related Disorders. 69: 104-110. PMID 31731260 DOI: 10.1016/J.Parkreldis.2019.06.014 |
0.469 |
|
| 2019 |
Simuni T, Uribe L, Cho HR, Caspell-Garcia C, Coffey CS, Siderowf A, Trojanowski JQ, Shaw LM, Seibyl J, Singleton A, Toga AW, Galasko D, Foroud T, Tosun D, Poston K, et al. Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study. The Lancet. Neurology. PMID 31678032 DOI: 10.1016/S1474-4422(19)30319-9 |
0.474 |
|
| 2019 |
Ryman SG, Poston KL. MRI biomarkers of motor and non-motor symptoms in Parkinson's disease. Parkinsonism & Related Disorders. 73: 85-93. PMID 31629653 DOI: 10.1016/j.parkreldis.2019.10.002 |
0.318 |
|
| 2019 |
Sundaram S, Hughes RL, Peterson E, Müller-Oehring EM, Brontë-Stewart HM, Poston KL, Faerman A, Bhowmick C, Schulte T. Establishing a framework for neuropathological correlates and glymphatic system functioning in Parkinson's disease. Neuroscience and Biobehavioral Reviews. PMID 31132378 DOI: 10.1016/J.Neubiorev.2019.05.016 |
0.388 |
|
| 2019 |
Cholerton B, Weiner MW, Nosheny RL, Poston KL, Scott Mackin R, Tian L, Ashford JW, Montine TJ. Cognitive Performance in Parkinson's Disease in the Brain Health Registry. Journal of Alzheimer's Disease : Jad. PMID 30909225 DOI: 10.3233/Jad-181009 |
0.42 |
|
| 2019 |
Peterson B, Armstrong M, Galasko D, Galvin JE, Goldman J, Irwin D, Paulson H, Kaufer D, Leverenz J, Lunde A, McKeith IG, Siderowf A, Taylor A, Amodeo K, Barrett M, ... ... Poston K, et al. Lewy Body Dementia Association's Research Centers of Excellence Program: Inaugural Meeting Proceedings. Alzheimer's Research & Therapy. 11: 23. PMID 30867052 DOI: 10.1186/S13195-019-0476-1 |
0.366 |
|
| 2019 |
Shahid M, Kim J, Leaver K, Hendershott T, Zhu D, Cholerton B, Henderson VW, Tian L, Poston KL. An increased rate of longitudinal cognitive decline is observed in Parkinson's disease patients with low CSF Aß42 and an APOE ε4 allele. Neurobiology of Disease. PMID 30826425 DOI: 10.1016/j.nbd.2019.02.023 |
0.39 |
|
| 2019 |
Hendershott TR, Zhu D, Llanes S, Zabetian CP, Quinn J, Edwards KL, Leverenz JB, Montine T, Cholerton B, Poston KL. Comparative sensitivity of the MoCA and Mattis Dementia Rating Scale-2 in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 34: 285-291. PMID 30776152 DOI: 10.1002/Mds.27575 |
0.35 |
|
| 2018 |
Marek K, Chowdhury S, Siderowf A, Lasch S, Coffey CS, Caspell-Garcia C, Simuni T, Jennings D, Tanner CM, Trojanowski JQ, Shaw LM, Seibyl J, Schuff N, Singleton A, Kieburtz K, ... ... Poston K, et al. The Parkinson's progression markers initiative (PPMI) - establishing a PD biomarker cohort. Annals of Clinical and Translational Neurology. 5: 1460-1477. PMID 30564614 DOI: 10.1002/Acn3.644 |
0.535 |
|
| 2018 |
Kim J, Zhang K, Cai W, YorkWilliams S, I Ua Cruadhlaoich MA, Llanes S, Menon V, Poston KL. Dopamine-Related Dissociation of Cortical and Subcortical Brain Activations in Cognitively Unimpaired Parkinson's Disease Patients OFF and ON Medications. Neuropsychologia. PMID 30040957 DOI: 10.1016/J.Neuropsychologia.2018.07.024 |
0.391 |
|
| 2018 |
Simuni T, Siderowf A, Lasch S, Coffey CS, Caspell-Garcia C, Jennings D, Tanner CM, Trojanowski JQ, Shaw LM, Seibyl J, Schuff N, Singleton A, Kieburtz K, Toga AW, Mollenhauer B, ... ... Poston K, et al. Longitudinal change of clinical and biological measures in early Parkinson's disease: Parkinson's progression markers initiative cohort. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 29572948 DOI: 10.1002/Mds.27361 |
0.499 |
|
| 2018 |
Cholerton B, Johnson CO, Fish B, Quinn JF, Chung KA, Peterson-Hiller AL, Rosenthal LS, Dawson TM, Albert MS, Hu SC, Mata IF, Leverenz JB, Poston KL, Montine TJ, Zabetian CP, et al. Sex differences in progression to mild cognitive impairment and dementia in Parkinson's disease. Parkinsonism & Related Disorders. PMID 29478836 DOI: 10.1016/J.Parkreldis.2018.02.007 |
0.383 |
|
| 2018 |
Jehangir N, Yu CY, Song J, Shariati MA, Binder S, Beyer J, Santini V, Poston K, Liao YJ. Slower saccadic reading in Parkinson's disease. Plos One. 13: e0191005. PMID 29364897 DOI: 10.1371/Journal.Pone.0191005 |
0.46 |
|
| 2017 |
Ng B, Varoquaux G, Poline JB, Thirion B, Greicius MD, Poston KL. Distinct alterations in Parkinson's medication-state and disease-state connectivity. Neuroimage. Clinical. 16: 575-585. PMID 28971008 DOI: 10.1016/J.Nicl.2017.09.004 |
0.344 |
|
| 2017 |
Niethammer M, Tang CC, LeWitt PA, Rezai AR, Leehey MA, Ojemann SG, Flaherty AW, Eskandar EN, Kostyk SK, Sarkar A, Siddiqui MS, Tatter SB, Schwalb JM, Poston KL, Henderson JM, et al. Long-term follow-up of a randomized AAV2-GAD gene therapy trial for Parkinson's disease. Jci Insight. 2: e90133. PMID 28405611 DOI: 10.1172/Jci.Insight.90133 |
0.342 |
|
| 2016 |
Yu CY, Lee T, Shariati MA, Santini V, Poston K, Liao YJ. Abnormal eye movement behavior during reading in Parkinson's disease. Parkinsonism & Related Disorders. PMID 27592009 DOI: 10.1016/J.Parkreldis.2016.08.008 |
0.481 |
|
| 2016 |
Warden C, Hwang J, Marshall A, Fenesy M, Poston KL. The effects of dopamine on digit span in Parkinson's disease. Journal of Clinical Movement Disorders. 3: 5. PMID 26955482 DOI: 10.1186/s40734-016-0033-z |
0.362 |
|
| 2015 |
Poston KL, YorkWilliams S, Zhang K, Cai W, Everling D, Tayim FM, Llanes S, Menon V. Compensatory Neural Mechanisms in Cognitively Unimpaired Parkinson's Disease. Annals of Neurology. PMID 26696272 DOI: 10.1002/Ana.24585 |
0.364 |
|
| 2015 |
Leaver K, Poston KL. Do CSF Biomarkers Predict Progression to Cognitive Impairment in Parkinson's disease patients? A Systematic Review. Neuropsychology Review. 25: 411-23. PMID 26626621 DOI: 10.1007/s11065-015-9307-8 |
0.328 |
|
| 2015 |
Warren Olanow C, Bartus RT, Baumann TL, Factor S, Boulis N, Stacy M, Turner DA, Marks W, Larson P, Starr PA, Jankovic J, Simpson R, Watts R, Guthrie B, Poston K, et al. Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial. Annals of Neurology. 78: 248-57. PMID 26061140 DOI: 10.1002/Ana.24436 |
0.325 |
|
| 2014 |
YorkWilliams S, Poston KL. What light have resting state fMRI studies shed on cognition and mood in Parkinson's disease? Journal of Clinical Movement Disorders. 1: 4. PMID 26788330 DOI: 10.1186/2054-7072-1-4 |
0.367 |
|
| 2014 |
Müller-Oehring EM, Sullivan EV, Pfefferbaum A, Huang NC, Poston KL, Bronte-Stewart HM, Schulte T. Task-rest modulation of basal ganglia connectivity in mild to moderate Parkinson's disease. Brain Imaging and Behavior. PMID 25280970 DOI: 10.1007/S11682-014-9317-9 |
0.332 |
|
| 2010 |
Tang CC, Poston KL, Eckert T, Feigin A, Frucht S, Gudesblatt M, Dhawan V, Lesser M, Vonsattel JP, Fahn S, Eidelberg D. Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis. The Lancet. Neurology. 9: 149-58. PMID 20061183 DOI: 10.1016/S1474-4422(10)70002-8 |
0.314 |
|
| 2007 |
Poston KL, Waters C. Zydis selegiline in the management of Parkinson's disease. Expert Opinion On Pharmacotherapy. 8: 2615-24. PMID 17931095 DOI: 10.1517/14656566.8.15.2615 |
0.332 |
|
| Show low-probability matches. |